首页> 外文期刊>Molecular Therapy - Methods & Clinical Development >Conditionally replicating adenovirus prevents pluripotent stem cell–derived teratoma by specifically eliminating undifferentiated cells
【24h】

Conditionally replicating adenovirus prevents pluripotent stem cell–derived teratoma by specifically eliminating undifferentiated cells

机译:有条件复制的腺病毒通过特异性消除未分化的细胞来防止多能干细胞畸胎瘤

获取原文
           

摘要

Incomplete abolition of tumorigenicity creates potential safety concerns in clinical trials of regenerative medicine based on human pluripotent stem cells (hPSCs). Here, we demonstrate that conditionally replicating adenoviruses that specifically target cancers using multiple factors (m-CRAs), originally developed as anticancer drugs, may also be useful as novel antitumorigenic agents in hPSC-based therapy. The survivin promoter was more active in undifferentiated hPSCs than the telomerase reverse transcriptase (TERT) promoter, whereas both promoters were minimally active in differentiated normal cells.
机译:在基于人多能干细胞(hPSC)的再生医学临床试验中,不完全取消致瘤性会带来潜在的安全隐患。在这里,我们证明了使用多种因子(m-CRA)特异性靶向癌症的条件复制腺病毒(最初开发为抗癌药物)也可能在基于hPSC的治疗中用作新型抗肿瘤药。 survivin启动子在未分化的hPSC中比端粒酶逆转录酶(TERT)启动子更具活性,而两个启动子在分化的正常细胞中的活性最低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号